Skip to main content
SpringerLink
Log in

Case Report: Hypersensitivity to 5-ASA Suppositories

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Das KM: Sulfasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Am 18:1-20, 1989

    Google Scholar 

  2. Collins JR: Adverse reactions to salicylazosulfapyridine (azulfidine) in the treatment of ulcerative colitis. South Med J 61:354-358, 1968

    Google Scholar 

  3. Das KM, Eastwood MA, McManus JPA, Sircus W: Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype. N Engl J Med 73:520-524, 1973

    Google Scholar 

  4. Taffet SL, Das KM: Sulfasalazine: Adverse effects and desensitization. Dig Dis Sci 28:833-842, 1983

    Google Scholar 

  5. Kanner RS, Tedesco FJ, Kalser MH: Azulfidine (sulfasalazine)-induced hepatic injury. Dig Dis Sci 23:956-958, 1978

    Google Scholar 

  6. Mihas AA, Goldenberg DJ, Slaughter RL: Sulfasalazine toxic reactions: Hepatitis, fever and skin rash with hypocomplementemia and immune complexes. JAMA 239:2590-2591, 1978

    Google Scholar 

  7. Gulley RM, Mirza A, Kelly CE: Hepatotoxicity of salicyclazo-sulfapyridine: A case report and review of the literature. Am J Gastroenterol 72:561-564, 1979

    Google Scholar 

  8. Poland GA, Love KR: Marked atypical lymphocytosis, hepatitis and skin rash in sulphasalazine drug allergy. Am J Med 81:707-708, 1986

    Google Scholar 

  9. Das KM, Eastwood MA: Acetylation polymorphism of sulfapyridine in patients with ulcerative colitis and Crohn's disease. Clin Pharmacol Ther 18:514-520, 1975

    Google Scholar 

  10. Robinson MG: New oral salicylates in the therapy of chronic idiopathic inflammatory bowel disease. Gastroenterol Clin North Am 18:43-50, 1989

    Google Scholar 

  11. Chan RP, Pope DJ, Gilbert AP, Sacra PJ, Barun JH, Lennard-Jones JE: Studies of two novel sulfasalazine analogs, ipsalazide and balsalazide. Dig Dis Sci 28:609-615, 1983

    Google Scholar 

  12. Rao SS, Cann PA, Holdsworth CD: Clinical experience of the tolerance of mesalazine and olsalazine in patients intolerant of sulphasalazine. Scand J Gastroenterol 22:332-336, 1987

    Google Scholar 

  13. Turunen U, Elomaa I, Anttila VJ, Seppala K: Mesalazine tolerance in patients with inflammatory bowel disease and previous intolerance or allergy to sulphasalazine or sulphonamides. Scand J Gastroenterol 22:798-802, 1987

    Google Scholar 

  14. Rachmilewitz D: Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: A randomized trial. BMJ 298:82-86, 1989

    Google Scholar 

  15. Riley SA, Mani V, Goodman MJ, Herd ME, Dott S, Tornberg LA: Comparison of delayed release 5-aminosalicylic acid (mesalazine) and sulphasalazine in treatment of mild to moderate ulcerative colitis relapse. Gut 29:669-674, 1988

    Google Scholar 

  16. Campieri M, Lanfranchi GA, Brignola C, Bazzochi G, Minguzzi MR, Calari MT: 5-Aminosalicylic acid as a rectal enema in ulcerative colitis patients unable to take sulphasalazine. Lancet 1:403, 1984

    Google Scholar 

  17. Biddle WL, Greenberger N, Swan JT, McPhee NS, Miner PB Jr: 5-Aminosalicylic acid enemas: Effective agent in maintaining remission in left-sided ulcerative colitis. Gastroenterology 94:1705-1709, 1988

    Google Scholar 

  18. Campieri M, Lanfranchi GA, Bazzochi G, Brignola C, Sart F, Franzin G, Battocchia A, Labo G, Palmonte PR: Treatment of ulcerative colitis with high dose 5-aminosalicylic acid enemas. Lancet 2:270-271, 1981

    Google Scholar 

  19. Guarino J, Chatzinoff M, Berk T, Friedman LS: 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: Longterm results. Am J Gastroenterol 82:732-737, 1987

    Google Scholar 

  20. Sutherland LR, Martin F, Greeg S, Robinson M, Greenberger N, Saibil F, Martin T, Sparr J, Prokipchuk E, Burgen L: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology 92:1894-1898, 1987

    Google Scholar 

  21. Friedman LS, Richter JM, Kirkham SE, DeMonaco HJ, May RJ: 5-Aminosalicylic acid enemas in refractory distal ulcerative colitis: A randomized controlled trial. Am J Gastroenterol 81:412-418, 1986

    Google Scholar 

  22. Sninsky CA, Cort DH, Shanahan F, Powers BJ, Sessions JT, Pruitt RF, Jacobs WH, Lo SK, Targan SR, Corda JJ: Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. A multicenter study. Ann Intern Med 115:350-355, 1991

    Google Scholar 

  23. Schroeder KW, Tremaine WJ, Ilstrup DM: Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 3317:1625-1629, 1987

    Google Scholar 

  24. Campieri M, Lanfranchi GA, Bertoni F, Brignola C, Bazzochi G, Minguzzi MR, Labo G: A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis. Digestion 29:231-234, 1984

    Google Scholar 

  25. Gandolfo J, Farthing M, Powers G, Eagen K, Goldberg M, Berman P, Kaplan M: 4-Aminosalicylic acid retention enemas in the treatment of distal colitis. Dig Dis Sci 32:700-704, 1987

    Google Scholar 

  26. Ginsberg AL, Beck LS, McIntosh TM, Nochomovitz LE: Treatment of left-sided ulcerative colitis with 4-aminosalicylic acid enemas: A double-blind, placebo-controlled trial. Ann Intern Med 108:195-199, 1988

    Google Scholar 

  27. Selby WS, Bennett MK, Jewell DP: Topical treatment of distal ulcerative colitis with 4-aminosalicylic acid enemas. Digestion 29:231-234, 1984

    Google Scholar 

  28. Ginsberg AL: Topical salicylate therapy (4-ASA and 5-ASA enemas). Gastroenterol Clin North Am 18:35-42, 1989

    Google Scholar 

  29. O'Donnell LJD, Arvind AS, Hoang P, Cameron D, Talbot JC, Jewell DP, Lennard-Jones JE, Farthing MJ: Double blind, controlled trial of 4-aminosalicylic acid and prednisolone enemas in distal ulcerative colitis. Gut 33:947-949, 1992

    Google Scholar 

  30. Ginsberg AL, Davis ND, Nochomovitz LE: Placebo-controlled trial of ulcerative colitis with oral 4-aminosalicylic acid. Gastroenterology 102:448-452, 1992

    Google Scholar 

  31. Fardy JM, Lloyd DA, Reynolds RDE: Adverse effects with oral 5-aminosalicylic acid. J Clin Gastroenterol 10:635-637, 1988

    Google Scholar 

  32. Brimblecombe R: Mesalazine: A global safety event. Scand J Gastroenterol 25(suppl):66-68, 1990

    Google Scholar 

  33. Niv Y: Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis. Isr J Med Sci 23:1161-1163, 1987

    Google Scholar 

  34. Sachedina B, Saibil F, Cohen LB, Whittey J: Acute pancreatitis due to 5-aminosalicylate. Ann Intern Med 110:490-492, 1989

    Google Scholar 

  35. Fiorentini MT, Fracchia M, Galatola G, Barlotta A, DelaPiere M: Acute pancreatitis during oral 5-aminosalicylic acid therapy. Dig Dis Sci 35:1180-1182, 1990

    Google Scholar 

  36. Deprez P, Descamps C, Fiasse R: Pancreatitis induced by 5-aminosalicylic acid. Lancet 2:445-446, 1989 (letter)

    Google Scholar 

  37. Kristensen KS, Hoegholm A, Buhr L, Friis S: Fatal myocarditis associated with mesalazine. Lancet 335:605, 1990 (letter)

    Google Scholar 

  38. Hautekeete ML, Bourgeois N, Potvin P, Duville L, Reynaert H, Devis G, Adler M, Kloppel G: Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine. Gastroenterology 103:1925-1927, 1992

    Google Scholar 

  39. Witte T, Olbricht CJ, Koch KM: Interstitial nephritis associated with 5-aminosalicylic acid. Nephron 67:481-482, 1994

    Google Scholar 

  40. Thuluvath PJ, Ninkovic M, Calam J, Anderson M: Mesalazine induced interstitial nephritis. Gut 35:1493-1496, 1994

    Google Scholar 

  41. Woodward DK: Peripheral neuropathy and mesalazine. BMJ 299:1224, 1989 (letter)

    Google Scholar 

  42. Campieri M, Lanfranchi GA, Boschi S, Brignola C, Bazzocchi G, Gionchetti P, Mingozzi MR, Belluzzi A, Labo G: Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis: Studies on rectal absorption and excretion. Gut 26:400-405, 1985

    Google Scholar 

  43. Isaacs KL, Murphy D: Pancreatitis after rectal administration of 5-aminosalicylic acid. J Clin Gastroenterol 12:198-199, 1990

    Google Scholar 

  44. FDA: Rare adverse reaction with rowasa. FDA Drug Bull 19:17-18, 1989

    Google Scholar 

Download references

Authors
  1. Marie L. Borum
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allen Ginsberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borum, M.L., Ginsberg, A. Case Report: Hypersensitivity to 5-ASA Suppositories. Dig Dis Sci 42, 1076–1078 (1997). https://doi.org/10.1023/A:1018857607739

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1018857607739

Search

Navigation